Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Jingting Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3128-9762; OpenAlex author ID A5006800281, A5112505192. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer. First author DOI 10.5306/wjco.v15.i11.1404↗
  2. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3. Co-author DOI 10.1038/cddis.2017.525↗
  3. miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells. Co-author DOI 10.1007/s10620-012-2400-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangyu Li · 1 shared paper, 2024 · strength 0.46
  2. Haijiao Yan · 2 shared papers, 2012–2017 · strength 0.10
  3. Liangrong Shi · 1 shared paper, 2017 · strength 0.07
  4. Changping Wu · 1 shared paper, 2017 · strength 0.07
  5. Changping Wu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.